Literature DB >> 9571353

Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.

T Yamanouchi1, T Kawasaki, T Yoshimura, T Inoue, E Koshibu, N Ogata, H Funato, I Akaoka, H Miyashita.   

Abstract

OBJECTIVE: This prospective study was designed to elucidate the relationship between the serum level of 1,5-anhydroglucitol (1,5AG) and the urinary excretion of N-acetylglucosaminidase (NAG) and albumin in patients who were in the early stages of diabetes. RESEARCH DESIGN AND METHODS: A total of 1,062 male nondiabetic subjects with impaired glucose tolerance were monitored for blood glucose level once every 2-3 months, and the values were evaluated. Of these 1,062 subjects, 112 showed a worsening of glycemia during the observation period to the level seen in diabetes. We began to monitor the glycemia and parameters of renal damage in the 112 patients from the onset of diabetes.
RESULTS: The urinary excretion of NAG and albumin were elevated even at the onset of diabetes. The abnormal excretion of NAG and albumin was associated with a change in serum 1,5AG and was quickly reversible when the serum 1,5AG improved. In the 3 years after the onset of diabetes, we obtained at least 18 measurements of one parameter for each patient and calculated the mean. Urinary NAG was found to be significantly correlated with the fasting plasma level of glucose (FPG; r = 0.512, P < 0.0001), the level of HbA1 (r = 0.351, P = 0.001), and the level of 1,5AG (r = -0.790, P < 0.0001). The urinary excretion of albumin was weakly but significantly correlated with levels of FPG (r = 0.383, P < 0.0001) and HbA1 (r = 0.337, P < 0.0001), but it was more strongly correlated with 1,5AG (r = -0.632, P < 0.0001). The level of 1,5AG was significantly correlated with FPG (r = -0.681, P < 0.0001) and HbA1 (r = -0.609, P < 0.0001).
CONCLUSIONS: When the renal damage is not severe, the serum level of 1,5AG appeared to be an indicator of the reversible renal damage caused by hyperglycemia, as well as of the severity of the glycemia itself.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571353     DOI: 10.2337/diacare.21.4.619

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Low levels of C-peptide have clinical significance for established Type 1 diabetes.

Authors:  W M Kuhtreiber; S L L Washer; E Hsu; M Zhao; P Reinhold; D Burger; H Zheng; D L Faustman
Journal:  Diabet Med       Date:  2015-08-16       Impact factor: 4.359

2.  Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).

Authors:  Elizabeth F O Kern; Penny Erhard; Wanjie Sun; Saul Genuth; Miriam F Weiss
Journal:  Am J Kidney Dis       Date:  2010-05       Impact factor: 8.860

3.  1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure.

Authors:  Lingjian Zhang; Yalei Zhao; Zhongyang Xie; Lanlan Xiao; Qingqing Hu; Qian Li; Shima Tang; Jie Wang; Lanjuan Li
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

4.  Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.

Authors:  Motoshi Ouchi; Kenzo Oba; Taro Saigusa; Kentaro Watanabe; Makoto Ohara; Noriaki Matsumura; Tatsuya Suzuki; Naohiko Anzai; Shuichi Tsuruoka; Masahiro Yasutake
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-09       Impact factor: 3.738

5.  Urinary N-acetyl-β-D-glucosaminidase levels are positively correlated with 2-hr plasma glucose levels during oral glucose tolerance testing in prediabetes.

Authors:  Motoshi Ouchi; Tatsuya Suzuki; Masao Hashimoto; Masayuki Motoyama; Makoto Ohara; Kazunari Suzuki; Yoshimasa Igari; Kentaro Watanabe; Hiroshi Nakano; Kenzo Oba
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

6.  Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.

Authors:  Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Journal:  Cardiovasc Diabetol       Date:  2014-06-13       Impact factor: 9.951

7.  Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.

Authors:  So Ra Kim; Yong-Ho Lee; Sang-Guk Lee; Eun Seok Kang; Bong-Soo Cha; Jeong-Ho Kim; Byung-Wan Lee
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin.

Authors:  Motoshi Ouchi; Kenzo Oba; Kohei Kaku; Hideki Suganami; Akihiro Yoshida; Yasunori Fukunaka; Promsuk Jutabha; Asuka Morita; Naoyuki Otani; Keitaro Hayashi; Tomoe Fujita; Tatsuya Suzuki; Masahiro Yasutake; Naohiko Anzai
Journal:  Diabetes Obes Metab       Date:  2018-01-08       Impact factor: 6.577

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.